Open-label observational study to assess the efficacy and safety of aprepitant for chemotherapy-induced nausea and vomiting prophylaxis in Indian patients receiving chemotherapy with highly emetogenic chemotherapy/moderately emetogenic chemotherapy regimens

CONTEXT: Currently, there is limited data on the prevention of chemotherapy-induced nausea and vomiting (CINV) in Indian population with aprepitant containing regimens. AIMS: The aim was to assess the Efficacy and Safety of Aprepitant for the prevention of nausea and vomiting associated with highly...

Descripción completa

Detalles Bibliográficos
Autores principales: Hingmire, Sachin, Raut, Nirmal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
CLINICAL TRIAL: Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382794/
https://www.ncbi.nlm.nih.gov/pubmed/25839011
http://dx.doi.org/10.4103/2278-330X.149923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382794/
https://www.ncbi.nlm.nih.gov/pubmed/25839011
http://dx.doi.org/10.4103/2278-330X.149923

Ejemplares similares